NCT01735955 2024-02-08Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored StudyNovartisPhase 4 Completed57 enrolled 8 charts
NCT01957176 2022-12-30A Rollover Study to Provide Continued Treatment With EltrombopagNovartisPhase 4 Completed22 enrolled 9 charts
NCT02228382 2021-12-30Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase InhibitorsPfizerPhase 4 Terminated163 enrolled 27 charts
NCT01201811 2019-12-05Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)CelgenePhase 4 Completed44 enrolled 26 charts
NCT00361140 2017-03-03Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)H. Lee Moffitt Cancer Center and Research InstitutePhase 4 Completed72 enrolled 10 charts